FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2785065020> ?p ?o ?g. }

• W2785065020 abstract "Introduction Paracetamol is a mainstay analgesic for neonatal pain and is increasingly used for management of patent ductus arteriosus (PDA) in very premature infants. The BNF for Children (BNFC) gives no dose recommendations for babies <28 weeks gestational age (GA) for analgesia and no recommendations for management of PDA. A recent review 1 of current literature only covered babies of ≥32 weeks gestation. We report on the paracetamol levels and safety profiles obtained in thirteen babies of <28 weeks GA, using an extended dosage regimen 2 over five days with maximum daily dose of 60 mg/kg/day; twice that recommended by the BNFC for analgesia in infants <32 weeks gestation. Method Babies <28 weeks GA, received regular paracetamol for five days intravenously for PDA 3 based on the following regimen initially introduced to the unit as part of a clinical trial (PDA TOLERATE) 4 babies did not have to participate in the trial to receive paracetamol for PDA. Regimen: 20 mg/kg loading dose followed by 10 or 12.5 mg/kg QID depending on corrected gestational age (CGA) lower dose for those 23+0 to 25+6 and =7 days at time of treatment, incrementing to a maximum of 15 mg/kg QID. Target paracetamol levels were 1520 mg/l with dose reduction if >25 mg/l and discontinuation if >40 mg/l. Since the major concern about paracetamol is liver toxicity plasma transaminases and bilirubin were obtained before and after (within 96 hours) treatment. Results Thirteen babies were treated with paracetamol for PDA. Median gestation at birth was 24+3 weeks (range 23+2–26+2) with a median CGA at treatment of 26+4 weeks (range 25+3–28+0). Median weight was 735 g (range 520 g – 990 g). All babies had paracetamol levels <25 mg/L with a median level of 12.7 mg/L (range 7–24). No dose reductions were required. Serum transaminases and bilirubin were normal before and after treatment. There were no clinical gastrointestinal side effects. Conclusion These data suggests these higher doses of paracetamol may be safe for babies of <28 weeks gestation requiring regular dosing, for up to five days, regardless of indication. Paracetamol levels obtained were lower than the target levels set for PDA TOLERATE but consistent with weight based pharmacokinetic models in moderate preterm and term infants in previous studies. 4 Given the variation in levels obtained it may be beneficial to monitor paracetamol levels in babies receiving regular dosing. References Mian P, Knibbe CA, Tibboel D, et al. What is the dose of intravenous paracetamol for pain relief in neonates?Arch Dis Child2017;102:653–654. El-Khuffash A, Jain A, Corcoran D, et al. Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies. Pediatr Res2014;76(3):238–244. Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus (PDA:TOLERATE) . ClinicalTrials.gov Identifier USA NCT0195832, NHS HRA UK Clinicaltrials.gov identifier NCT01958320 . Allegaert K, Palmer GM, Anderson BJ. The pharmacokinetics of intravenous paracetamol in neonates: Size matters most. Arch Dis Child2011;96:575–5802." @default.
• W2785065020 created "2018-02-02" @default.
• W2785065020 creator A5003937754 @default.
• W2785065020 creator A5069653177 @default.
• W2785065020 date "2018-01-19" @default.
• W2785065020 modified "2023-09-27" @default.
• W2785065020 title "SP10 Paracetamol levels following intravenous therapy in neonates less than 28 weeks gestation" @default.
• W2785065020 doi "https://doi.org/10.1136/archdischild-2017-314584.10" @default.
• W2785065020 hasPublicationYear "2018" @default.
• W2785065020 type Work @default.
• W2785065020 sameAs 2785065020 @default.
• W2785065020 citedByCount "0" @default.
• W2785065020 crossrefType "journal-article" @default.
• W2785065020 hasAuthorship W2785065020A5003937754 @default.
• W2785065020 hasAuthorship W2785065020A5069653177 @default.
• W2785065020 hasConcept C141071460 @default.
• W2785065020 hasConcept C2778376644 @default.
• W2785065020 hasConcept C2778715236 @default.
• W2785065020 hasConcept C2778722691 @default.
• W2785065020 hasConcept C2779234561 @default.
• W2785065020 hasConcept C2780820201 @default.
• W2785065020 hasConcept C2781236024 @default.
• W2785065020 hasConcept C2781413609 @default.
• W2785065020 hasConcept C42219234 @default.
• W2785065020 hasConcept C46973012 @default.
• W2785065020 hasConcept C54355233 @default.
• W2785065020 hasConcept C71924100 @default.
• W2785065020 hasConcept C86803240 @default.
• W2785065020 hasConceptScore W2785065020C141071460 @default.
• W2785065020 hasConceptScore W2785065020C2778376644 @default.
• W2785065020 hasConceptScore W2785065020C2778715236 @default.
• W2785065020 hasConceptScore W2785065020C2778722691 @default.
• W2785065020 hasConceptScore W2785065020C2779234561 @default.
• W2785065020 hasConceptScore W2785065020C2780820201 @default.
• W2785065020 hasConceptScore W2785065020C2781236024 @default.
• W2785065020 hasConceptScore W2785065020C2781413609 @default.
• W2785065020 hasConceptScore W2785065020C42219234 @default.
• W2785065020 hasConceptScore W2785065020C46973012 @default.
• W2785065020 hasConceptScore W2785065020C54355233 @default.
• W2785065020 hasConceptScore W2785065020C71924100 @default.
• W2785065020 hasConceptScore W2785065020C86803240 @default.
• W2785065020 hasLocation W27850650201 @default.
• W2785065020 hasOpenAccess W2785065020 @default.
• W2785065020 hasPrimaryLocation W27850650201 @default.
• W2785065020 hasRelatedWork W1523570603 @default.
• W2785065020 hasRelatedWork W177019059 @default.
• W2785065020 hasRelatedWork W1849178357 @default.
• W2785065020 hasRelatedWork W1971310527 @default.
• W2785065020 hasRelatedWork W2006817615 @default.
• W2785065020 hasRelatedWork W2007577550 @default.
• W2785065020 hasRelatedWork W2020896435 @default.
• W2785065020 hasRelatedWork W2051846803 @default.
• W2785065020 hasRelatedWork W2052885250 @default.
• W2785065020 hasRelatedWork W2075070761 @default.
• W2785065020 hasRelatedWork W2082605022 @default.
• W2785065020 hasRelatedWork W2086605257 @default.
• W2785065020 hasRelatedWork W2409727952 @default.
• W2785065020 hasRelatedWork W2554963505 @default.
• W2785065020 hasRelatedWork W2595074754 @default.
• W2785065020 hasRelatedWork W2730212004 @default.
• W2785065020 hasRelatedWork W2897445846 @default.
• W2785065020 hasRelatedWork W2994348686 @default.
• W2785065020 hasRelatedWork W3121603404 @default.
• W2785065020 hasRelatedWork W161126530 @default.
• W2785065020 isParatext "false" @default.
• W2785065020 isRetracted "false" @default.
• W2785065020 magId "2785065020" @default.
• W2785065020 workType "article" @default.